News - Europabio - Page 17

About us
- What we do
- Who we are
Members
- EuropaBio Members
- About Membership
How we work
Activities
News & Events
- News
- Events
Library

Become a member

✕

05/03/2021

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe
01/03/2021

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi
01/03/2021

EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme
24/02/2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback
15/02/2021

The Business of Biotechnology: Growing for Europe’s tomorrow
12/02/2021

EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion
12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare
04/02/2021

EuropaBio draft response to the IIA on European Health Data Space
02/02/2021

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)
29/01/2021

Building a European Health Union
28/01/2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation
20/01/2021

Revision of the EU legislation on medicines for children and rare diseases
24/12/2020

Joint Statement: Comitology Reform Threatens Innovation
20/12/2020

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation
30/11/2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
25/11/2020

An EU IP Action Plan for strong industrial ecosystems
25/11/2020

EuropaBio Statement on the EU Pharmaceutical Strategy
10/11/2020

Create sustainable bio-based and biodegradable plastics
02/11/2020

EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association
20/10/2020

EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making

1...15 16 17 18 19...22

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members

Staff

Privacy policy

Legal & cookies

Events

Newsroom

Become a member

© 2025 Europabio. All Rights Reserved. Designed by EYAS

Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.